Back to Journal

SM Journal of Gastroenterology & Hepatology

Outcomes and Safety of Open vs. Laparoscopic Surgery in Patients with Cirrhosis

[ ISSN : 3067-977X ]

Abstract Citation Abbreviations Introduction Methods Results Discussion Author Contributions References
Details

Received: 23-Mar-2015

Accepted: 28-Aug-2015

Published: 15-Sep-2015

Stanley Martin Cohen¹*, Aditya Dholakia², Thomas R VanderHeyden³, Anjana Pillai⁴ and Joseph Ahn⁵

¹Division of Gastroenterology and Liver Disease, Case Western Reserve University School of Medicine, USA
²Division of Gastroenterology, Loyola University Medical Center, Hepatology, and Nutrition, USA
³Michiana Gastroenterology Inc., USA
?Division of Hepatology, The Emory Clinic ‘B’, USA
?Director of Clinical Hepatology, Oregon Health and Science University, USA

Corresponding Author:

Stanley Martin Cohen, Medical Director, Hepatology, Digestive Health Institute, University Hospitals Case Medical Center, Division of Gastroenterology and Liver Disease, Case Western Reserve University School of Medicine, 11100 Euclid Avenue, Cleveland, OH 44106- 5066, Tel: 216 286-6757; Fax: 216 844- 7480; Email: stanley.cohen@uhhospitals. org

Keywords

Cirrhosis; Laparoscopic surgery; MELD score; Child-Pugh score

Abstract

Background & Aims: The risk of laparoscopic surgery in cirrhotics remains unclear. We report on outcome and safety of open versus laparoscopic surgery in cirrhotics.

Methods: Retrospective review of cirrhotics undergoing abdominal or pelvic surgery at a university hospital from 2000 to 2010. Pre-, intra-, and post-operative data was collected. Open and laparoscopic patients were compared for post-operative outcomes including minor and major complications, hepatic decompensation, and mortality. Patients were stratified by Child-Pugh and MELD scores, and emergent vs. elective surgery. 164 total patients were identified (131 open and 31 laparoscopic).

Results: There was significantly more intra-operative blood loss (p<0.001) and minor complications (p=0.043) in the open group, but no other significant differences between the laparoscopic and open patients. All 5 deaths occurred in open patients (p=0.58). Increasing Child and MELD scores were predictive of adverse events. Overall complications, hepatic decompensation (p=0.015) and death (p<0.022) were more common in open emergent compared to open elective cases. In open emergent Child C patients, 100% had major complications and hepatic decompensation and 67% died. Of emergent open MELD>20 patients, 100% had major complications, 67% had hepatic decompensation, and 33% died.

Conclusion: Open and laparoscopic surgical approaches for cirrhotics yielded similar safety and outcomes. Child and MELD scores were predictive of adverse outcomes. Emergent cases were more likely to have complications than elective cases. Further studies including larger numbers of emergent laparoscopic patients are needed to better ascertain the risk of laparoscopy in cirrhotics.

Citation

Cohen SM, Dholakia A, VanderHeyden TR, Pillai A and Ahn J. Outcomes and Safety of Open vs. Laparoscopic Surgery in Patients with Cirrhosis. J Gastroenterol. 2015;1(1):1001.

Abbreviations

ASA: American Association of Anesthesiologists; ERCP: Endoscopic Retrograde Cholangiopancreatogram; HD: Hepatic Decompensation; ICU: Intensive Care Unit; INR: International Normalized Ratio; MELD: Model for End-Stage Liver Disease; NIH: National Institutes of Health

Introduction

Despite advances in surgical management, surgery in cirrhotic patients still portends high morbidity and mortality [1-6]. Nevertheless, there remains a persistent need for surgery in these patients. Cirrhotic patients have a significant prevalence of cholelithiasis placing them at potentially greater need for cholecystectomy [7]. In addition, cirrhotic patients can have abdominal hernias, often exacerbated by ascites, which may require surgery. However, there have only been a limited number of studies that have delineated these risks and identified mechanisms to attenuate them. These studies have proposed several scoring systems to approximate the operative risk for open surgery. The most readily used is the Child-Pugh classification. Prior studies have shown significant post-operative mortality of 10%, 20-30%, and 60-80% in Child A, B, and C cirrhotic patients, respectively [2-4]. However, a more recent report did demonstrate much lower post-operative mortality rates of 2%, 12%, and 12% for Child A, B, and C patients, respectively [8].

The Model for End-Stage Liver Disease (MELD) score has also been utilized to estimate perioperative risk and mortality in cirrhotic patients [5,6,8,9]. Similar to the Child-Pugh data, post-operative mortality increased with higher MELD scores. Patients undergoing surgery with MELD scores of ≥ 17 had 30-day post-operative mortality of approximately 50-60% [5,6]. An odds ratio of 6.9 for post-operative mortality in cirrhotic patients with a MELD score > 17 undergoing surgery was reported [8].

Since the first laparoscopic cholecystectomy in 1985, this procedure has become the preferred approach for gallbladder removal. In 1992, the National Institute of Health (NIH) consensus statement indicated that patients with end-stage cirrhosis and portal hypertension were “usually not candidates for laparoscopic cholecystectomy [10].” However, several studies have shown that laparoscopy can be safe for patients with compensated cirrhosis when performed by experienced surgeons [11-14]. The majority of these studies were relatively small and retrospective. Some were uncontrolled while others used age- and sex-matched non-cirrhotic controls.

Although this data has led to a paradigm shift regarding cholecystectomy in patients with cirrhosis, only a few studies have looked at the safety and outcomes of other laparoscopic intra-abdominal and pelvic surgeries in cirrhotic patients [15-22]. In addition, these studies have been limited by relatively small sample sizes or lacked control groups of cirrhotic patients undergoing similar open procedures.

The purpose of this manuscript is to report the results from a large, single-center experience evaluating outcomes and adverse events in cirrhotic patients undergoing open and laparoscopic intra-abdominal and pelvic surgeries. The paper also focuses on comparing the adverse events between the open and laparoscopic groups.

Methods

A retrospective review was performed of all cirrhotic patients undergoing abdominal and pelvic surgery from 2000 to 2010 at a single university hospital. This protocol was approved by the hospital’s Institutional Review Board.

Cirrhotics who underwent any abdominal or pelvic surgery were identified from the electronic medical record database using appropriate ICD-9 codes. The electronic and paper charts were reviewed to confirm the diagnosis of cirrhosis (either based on laboratory studies, imaging and/or liver biopsy) and to capture clinical data regarding the surgical procedures including open vs. laparoscopic technique, emergent vs. elective nature of these procedures, and their outcomes. Liver transplantation surgery was excluded.

Data collected included pre-operative, intra-operative, and post-operative characteristics. Baseline characteristics including age, gender, etiology of cirrhosis, coagulation parameters, renal function, presence of encephalopathy, presence of ascites, albumin, bilirubin and the American Society of Anesthesiologists (ASA) score were obtained. An immediate pre-operative Child-Pugh and MELD score were calculated. Intra-operative variables included estimated blood loss, operative time, blood transfusion requirements, minor and major complications, and mortality. In patients undergoing laparoscopic procedures, the need for conversion to open surgery was also noted. Post-operative variables included 30-day mortality, hepatic decompensation, minor and major complications, and length of hospital stay.

Adverse events were defined as major complications, minor complications, hepatic decompensation, or death.

Major complications in the intra-operative period included significant hemodynamic changes in the patient, blood loss necessitating blood transfusion, or death. Major complications in the post-operative period included significant hemodynamic changes (resulting in transfer to the ICU setting or prevention of transfer to the floor from the ICU), any event necessitating transfer from the floor to the ICU, renal failure, severe infection/sepsis, need for repeat surgery, or mortality.

Minor complications were complications that did not meet the major complications criteria including mild-moderate hemodynamic alterations which did not result in transfer to the ICU or resolved with little or no intervention, post-operative ileus, and mild infections.

Hepatic decompensation included clinical development of signs or symptoms of worsening liver disease including significant worsening or development of bilirubin elevation (jaundice), hepatic encephalopathy, INR elevation, ascites, or variceal bleeding. 

Patients were divided by type of surgery (open versus laparoscopic), timing of surgery (emergent versus elective), and stratified by their Child and MELD scores. Emergent surgeries were defined as such in the operative report or as any surgery deemed necessary to prevent further immediate clinical compromise.

Statistical analysis was performed using Fisher-Exact, Student’s t-test and Mann-Whitney tests. A p-value of < 0.05 was considered to be statistically significant.

Results

164 cirrhotic patients underwent abdominal or pelvic surgery and met study entry criteria. Of these, 131 underwent open and 33 underwent laparoscopic surgery. The baseline characteristics are shown in Table 1. There were significantly more Child A patients in the laparoscopic group, and more Child B, MELD 12-20 and men in the open group.

Table 1: Baseline Characteristics.

 

Laparoscopic (n=33)

Open (n=131)

p-value

Age

60.0

60.1

0.541

Sex Ratio (M : F)

12 : 21

77 : 54

0.030

Albumin

3.3

2.9

0.464

ASA Class

2.8

3.1

0.746

Ascites

6 (18%)

40 (31%)

0.196

Bilirubin

1.2

1.9

0.763

Creatinine

1.3

1.1

0.425

Encephalopathy

1 (3%)

8 (6%)

0.688

INR

1.16

1.26

0.863

Child Score (mean)

6.1

6.9

0.998

Child A

24 (73%)

52 (40%)

0.0008

Child B

7 (21%)

68 (52%)

0.0017

Child C

2 (6%)

11 (8%)

1.000

MELD (mean)

9.8

11.5

0.984

MELD < 12

27 (82%)

87 (66%)

0.095

MELD 12-20

4 (12%)

41 (31%)

0.030

MELD > 20

2 (6%)

3 (2%)

0.264

There were a variety of cirrhosis etiologies. The only statistically significant differences were more patients with hepatitis C in the open group, and more patients with non-alcoholic fatty liver disease and autoimmune hepatitis in the laparoscopic group.

A wide variety of abdominal and pelvic surgeries were performed. These are shown in Table 2.

Table 2: Types of Surgery.

Type of Surgery

Laparoscopic Emergent

(n=1)

Open Emergent

(n=19)

Laparoscopic Elective

(n=32)

Open Elective

(n=112)

Hernia Repair

-

5

4

21

Exploratory Laparotomy

-

5

-

-

Cholecystectomy

-

4

14

15

Bowel Resection

-

3

1

9

Hysterectomy

-

1

2

6

Rupture Left Iliac Artery Repair

-

1

-

-

Hepatic Lobectomy

-

-

-

28

Hepatic Lobectomy + Cholecystectomy

-

-

-

5

Roux-en-Y GastricBypass + Cholecystectomy

-

-

-

3

Splenectomy

-

-

-

3

Nephrectomy

-

-

5

2

Cholecystectomy + Hernia Repair

-

-

-

2

Whipple Procedure

-

-

-

3

Subtotal Gastrectomy

-

-

-

2

Small Bowel Anastomosis

-

-

-

1

Abdominal Aortic Aneurysm Repair

-

-

-

1

Hepatic Lobectomy + Hernia Repair

-

-

-

1

Hepatic Lobectomy + Cholecystectomy +

Hernia Repair

-

-

-

1

Left Hemicolectomy + Cholecystectomy +

Hernia Repair

-

-

-

1

Intra-Abdominal Abcess Drainage

-

-

-

1

Pancreaticoduodenectomy

-

-

-

1

Cesarean Section

-

-

-

1

Transverse Loop Colostomy

-

-

-

1

Splenectomy + Cholecystectomy

-

-

-

1

PEG removal + Liver Biopsy

-

-

-

1

Pancreatectomy

-

-

1

1

Retroperitoneal Lymphadenectomy

-

-

-

1

Diagnostic Laparoscopy

-

-

2

-

Cystectomy

-

-

1

-

Appendectomy

1

-

1

-

Left Adrenalectomy

-

-

1

-

Median operative times were similar between the open and laparoscopic groups (159 vs. 146 minutes, respectively). Median intra-operative blood loss was significantly higher in the open group [200 vs. 30 cc, p<0.001)].

Three of the laparoscopic cases were converted to open procedures. One was a trauma patient with significant intra-abdominal bleeding at laparoscopy who was converted to better evaluate and treat the bleeding sources. The other two patients were converted to allow better visualization due to significant adhesions.

Figure 1 shows the adverse outcomes in the total cohort (open + laparoscopic) by Child class as well as MELD score. All aspects of adverse outcomes (major + minor complications, hepatic decompensation, and mortality) showed increases with worsening Child class and MELD score. For overall (major + minor) complications, there were statistically significant differences seen between Child A and B and Child A and C patients and between MELD < 12 and 12-20 and MELD < 12 and > 20 patients. Regarding hepatic decompensation, statistically significant differences were noted between Child A and B and Child A and C patients. Regarding mortality, statistical significance was only demonstrated between Child A and C patients.

Figure 1: Adverse Outcomes by Child Class and MELD Score.

Comparing open to laparoscopic patients, minor complications were seen significantly more often in the open group (11.5% vs. 0%, p=0.043). There were no significant differences in major complications (13% vs. 9.1%, p=0.767) or hepatic decompensation (16% vs. 9.1%, p=0.313) between the groups. Overall 30-day mortality was numerically greater in the open group, but did not reach statistical significance (3.8% vs. 0%), p=0.25).

Figure 2 shows the adverse outcomes in the open group versus the laparoscopic group, stratified by Child class and MELD score. Overall (major + minor) complications in the open group significantly increased as Child and MELD class worsened. The MELD 12-20 group had numerically less complications than the MELD >20 group, but this did not reach statistical significance (p=0.051). No significant differences were demonstrated among the laparoscopic groups.

Figure 2: Adverse Outcomes by Child Class and MELD Score.

Hepatic decompensation increased in the open group as Child class increased. This was only significantly different between the open Child A and C patients. In the laparoscopic group, Child B patients had significantly more hepatic decompensation than Child A patients. No significant differences could be demonstrated with increasing MELD score in either the open or the laparoscopic groups.

Mortality in Child A open patients was significantly lower than in Child C open patients. Despite numerical trends, there were no significant differences seen with worsening of MELD score.

The data was then evaluated to look for significant differences between the open and laparoscopic groups based on elective or emergent surgery. No adverse outcomes were noted in the single emergent laparoscopic patient while the elective laparoscopic patients had 9.4% major complications, 9.4% hepatic decompensation, and no mortality. The number of subjects was also too small to allow statistical comparisons.

Multiple adverse outcomes were seen in the open surgery groups. In the open emergent group, this included major complications in 36.8%, hepatic decompensation in 36.8%, and a 30-day mortality rate of 15.8%. Table 3 shows this data stratified by Child class and MELD score. The only statistically significant differences were more minor complications in the open emergent Child B patients, and more hepatic decompensation in the open emergent MELD < 12 patients. Of the 3 open emergent Child C patients, all had major complications and hepatic decompensation, and 2 died. These were numerically, but not significantly, higher than the elective Child C adverse outcomes. Of the 3 open emergent MELD > 20 patients, all had major complications, 2 had hepatic decompensation, and 1 died. Due to no open elective MELD > 20 patients in the study, statistical comparisons could not be made with this group.

Table 3: Overall Adverse Events in Open Emergent vs. Open Elective Patients Based on Child-Pugh score and MELD score.

Event

Open Emergent

Open Elective

p-value

Open Emergent

Open Elective

p-value

 

Minor

CPS A

 

(n=3)

 

0 (0%)

CPS A

 

(n=49)

 

2 (4.1%)

 

1.000

MELD<12

 

(n=5)

 

1 (20.0%)

MELD<12

 

(n=82)

 

5 (6.1%)

 

0.307

 

Minor

CPS B

 

(n=13)

6

(46.2%)

CPS B

 

(n=55)

 

5 (9.1%)

 

0.004

MELD 12-20

 

(n=11)

 

4 (36.4%)

MELD 12-20

 

(n=30)

 

4 (13.3%)

 

0.178

 

Minor

CPS C

 

(n=3)

 

0 (0%)

CPS C

 

(n=8)

 

2 (25%)

 

1.000

MELD>20

 

(n=3)

 

0 (0%)

MELD>20

 

(n=0)

 

-

 

NA

 

Major

CPS A

 

(n=3)

1

(33.3%)

CPS A

 

(n=49)

 

1 (2%)

 

0.113

MELD<12

 

(n=5)

 

2 (40.0%)

MELD<12

 

(n=82)

 

7 (8.5%)

 

0.081

 

Major

CPS B

 

(n=13)

3

(23.1%)

CPS B

 

(n=55)

 

6 (10.9%)

 

0.358

MELD 12-20

 

(n=11)

 

2 (18.2%)

MELD 12-20

 

(n=30)

 

4 (13.3%)

 

0.651

 

Major

CPS C

 

(n=3)

 

3 (100%)

CPS C

 

(n=8)

 

3 (37.5%)

 

0.182

MELD>20

 

(n=3)

 

3 (100%)

MELD>20

 

(n=0)

 

-

 

NA

 

HD

CPS A

 

(n=3)

1

(33.3%)

CPS A

 

(n=49)

 

2 (4.1%)

 

0.166

MELD<12

 

(n=5)

 

3 (60.0%)

MELD<12

 

(n=82)

 

9 (11.0%)

 

0.018

 

HD

CPS B

 

(n=13)

3

(23.1%)

CPS B

 

(n=55)

10

(18.2%)

 

0.703

MELD 12-20

 

(n=11)

 

2 (18.2%)

MELD 12-20

 

(n=30)

 

5 (16.7%)

 

0.694

 

HD

CPS C

 

(n=3)

 

3 (100%)

CPS C

 

(n=8)

 

2 (25%)

 

0.061

MELD>20

 

(n=3)

 

2 (66.7%)

MELD>20

 

(n=0)

 

-

 

NA

 

Mortality

CPS A

 

(n=3)

 

0 (0%)

CPS A

 

(n=49)

 

0 (0%)

 

1.000

MELD<12

 

(n=5)

 

0 (0%)

MELD<12

 

(n=82)

 

1.2 (1%)

 

1.000

 

Mortality

CPS B

 

(n=13)

 

1 (7.7%)

CPS B

 

(n=55)

 

2 (3.6%)

 

0.477

MELD 12-20

 

(n=11)

 

2 (18.2%)

MELD 12-20

 

(n=30)

 

1 (3.3%)

 

0.170

 

Mortality

CPS C

 

(n=3)

2

(66.7%)

CPS C

 

(n=8)

 

0 (0%)

 

0.054

MELD>20

 

(n=3)

 

1 (33.3%)

MELD>20

 

(n=0)

 

-

 

NA

Discussion

The operative risk for cirrhotic patients undergoing abdominal and pelvic surgery remains high despite improvements in medical and surgical care. Contributing factors include severity of the underlying liver disease as characterized by Child-Pugh and MELD scores, type of surgery, emergent versus elective surgery, and other non-liver comorbid medical conditions.

The majority of previous laparoscopic surgery outcome studies in cirrhotic patients have been limited to cholecystectomy. A meta analysis of 2005 cirrhotic patients compared laparoscopic and open cholecystectomy and showed mortality of 0.74% and 2%, respectively [23]. However, the authors felt that the quality of the evidence comparing laparoscopic and open cholecystectomy was “poor.” In addition, there was only minimal data on laparoscopic cholecystectomy in patients with decompensated (Child class B-C) cirrhosis. Data on cirrhotic patients undergoing non-cholecystectomy laparoscopic surgeries is even more limited.

Our current study looked at all cirrhotic patients undergoing any laparoscopic or open abdominal or pelvic surgery (except liver transplantation) between 2000 and 2010. We compared patients based on Child-Pugh and MELD stratifications and on emergent versus elective surgery.

As shown in Figure 1, combining laparoscopic and open patients, we confirmed what has been demonstrated in prior studies: Patients have more overall adverse events with worsening liver function. This was true for both Child-Pugh and MELD classifications.

Comparing open to laparoscopic patients, operative times were similar. However, intra-operative blood loss was significantly higher in the open group. Only 3 laparoscopic patients required conversion to open surgery, and none were related to surgical complications. In terms of comparing overall adverse outcomes, there were significantly more minor complications in the open group. There were no statistically significant differences between the groups for rates of major complications, hepatic decompensation, or mortality. All of the deaths (a total of 5 or 3.8%) occurred in open patients.

Regarding complications based on Child-Pugh class, there were no significant differences between the open and laparoscopic groups. However, there were significant differences within each group. In the open group, worsening Child class was associated with more overall (major + minor) complications, hepatic decompensation, and mortality (0% Child A vs. 18.2% Child C). In the laparoscopic group, worsening Child class was associated with significantly more hepatic decompensation (p=0.008 for Child B vs. A).

Similar findings were shown when the data was stratified by MELD class. Overall, there were no significant differences between the open and laparoscopic groups. However, within the open group, worsening MELD groups had more overall (major + minor) complications, hepatic decompensation, and mortality.

Emergent surgery is a known risk factor for worsening outcome in cirrhotic patients [5,6,8,9]. We noted a significant number of adverse events in the open emergent patients. There were numerically more minor complications, major complications, hepatic decompensation, and mortality in the open emergent (vs. open elective) group. 100% of Child C open emergent patients had major complications or hepatic decompensation, and 66.7% died. Similarly, in emergent open patients with MELD > 20, 100% had major complications, 66.7% had hepatic decompensation, and 33.3% died.

The strengths of this study were the large number and diversity of surgical procedures, the large number of laparoscopic cases, and the large number of comparison cirrhotic patients undergoing open surgery. Overall, there were 131 non-cholecystectomy cases, including 19 in the laparoscopy group. Unlike most prior studies, we looked at both Child-Pugh class and MELD score in evaluating the results. Despite a relatively small number of MELD > 20 and Child C patients, there were a large percentage of patients with Child-Pugh class B (46%).

The study was limited by its retrospective design with the attendant potential for selection bias. The decision of open versus laparoscopic approach was at the discretion of the surgeon. There was no way to capture the thought process used for these decisions. It is possible that many of the sicker patients underwent a more traditional open surgical approach.

The study was also limited by only a single patient undergoing emergent laparoscopic surgery and a relatively small number of patients with Child C or MELD > 20. This latter fact was most evident in open emergent patients (3 each with Child C and MELD > 20) where we saw large percentages of overall adverse events but couldn’t demonstrate statistical significance.

An additional limitation is whether this data can be generalized to other medical centers, especially community medical centers. In addition to the primary surgeon, our center had dedicated hepatobiliary surgeons, liver transplant surgeons, and a supporting team of hepatologists and anesthesiologists familiar with the care of cirrhotic patients. Such personnel may not be available in other centers.

In conclusion, in this group of cirrhotic patients who underwent surgery in a large, tertiary care center, there were no significant differences between open and laparoscopic approaches in terms of operative times, major complications, hepatic decompensation, and death. Emergent cases were more likely to have complications than elective cases. The risk of major and adverse outcomes increased with worsening Child-Pugh and MELD scores. Overall, Child-Pugh and MELD scores were more predictive of complications and hepatic decompensation than the surgical approach. There was no statistical difference between using Child or MELD scores to determine a risk of adverse events.

Ideally, prospective studies are needed with larger cohorts of cirrhotic patients undergoing laparoscopy to more definitively demonstrate the safety and efficacy of this approach. In the interim, accumulation of clinical experience such as this report will aid in the acceptance of laparoscopy in cirrhotic patients and assist in defining its optimal role in this challenging patient population.

Author Contributions

SM Cohen – study design and concept, analysis of data, drafting of paper, study supervision

A. Dholakia – acquisition of data, interpretation of data, drafting of paper

J. Ahn – study concept and design, analysis of data, drafting of paper

T VanderHeyden – acquisition of data

A. Pillai – study concept and design, critical review and revision of paper

References

1. Ziser A, Plevak DJ, Wiesner RH, Rakela J, Offord KP, Brown DL. Morbidity and mortality in cirrhotic patients undergoing anesthesia and surgery. Anesthesiology. 1999; 90: 42-53.

2. Garrison RN, Cryer HM, Howard DA, Polk HC Jr. Clarification of risk factors for abdominal operations in patients with hepatic cirrhosis. Ann Surg. 1984; 199: 648-655.

3. Mansour A, Watson W, Shayani V, Pickleman J. Abdominal operations in patients with cirrhosis: still a major surgical challenge. Surgery. 1997; 122: 730-735.

4. Neeff H, Mariaskin D, Spangenberg HC, Hopt UT, Makowiec F. Perioperative mortality after non-hepatic general surgery in patients with liver cirrhosis: an analysis of 138 operations in the 2000s using Child and MELD scores. J Gastointest Surg. 2011; 15: 1-11.

5. Teh SH, Nagorney DM, Stevens SR, Offord KP, Therneau TM, Plevak DJ, et al. Risk factors for mortality after surgery in patients with cirrhosis. Gastroenterology. 2007; 132: 1261-1269.

6. Farnsworth N, Fagan SP, Berger DH, Awad SS. Child-Turcotte-Pugh versus MELD score as a predictor of outcome after elective and emergent surgery in cirrhotic patients. Am J Surg. 2004; 188: 580-583.

7. Conte D, Fraquelli M, Fornari F, Lodi L, Bodini P, Buscarini L. Close relation between cirrhosis and gallstones: cross-sectional and longitudinal survey. Arch Intern Med. 1999; 159: 49-52.

8. Telem DA, Schiano T, Goldstone R, Han DK, Buch KE, Chin EH, et al. Factors that predict outcome of abdominal operations in patients with advanced cirrhosis. Clin Gastroenterol Hepatol. 2010; 8: 451-457, quiz e58.

9. Perkins L, Jeffries M, Patel T. Utility of preoperative scores for predicting morbidity after cholecystectomy in patients with cirrhosis. Clin Gastroenterol Hepatol. 2004; 2: 1123-1128.

10. Gallstones and laparoscopic cholecystectomy. NIH Consens Statement. 1992; 10: 1-28.

11. Cobb WS, Heniford BT, Burns JM, Carbonell AM, Matthews BD, Kercher KW. Cirrhosis is not a contraindication to laparoscopic surgery. Surg Endosc. 2005; 19: 418-423.

12. Leone N, Garino M, De Paolis P, Pellicano R, Fronda GR, Rizzetto M. Laparoscopic cholecystectomy in cirrhotic patients. Dig Surg. 2001; 18: 449-452.

13. Tuech JJ, Pessaux P, Regenet N, Rouge C, Bergamaschi R, Arnaud JP. Laparoscopic cholecystectomy in cirrhotic patients. Surg Laparosc Endosc Percutan Tech. 2002; 12: 227-231.

14. Sleeman D, Namias N, Levi D, Ward FC, Vozenilek J, Silva R, et al. Laparoscopic cholecystectomy in cirrhotic patients. J Am Coll Surg. 1998; 187: 400-403.

15. Yoon HM, Yang HK, Lee HJ, Park do J, Kim HH, Lee KU, et al. Comparison of liver function after laparoscopically assisted and open distal gastrectomies for patients with liver disease. Surg Endosc. 2011; 25: 1761-1765.

16. Xin Z, Qingguang L,Yingmin Y. Total laparoscopic versus open splenectomy and esophagogastric devascularization in the management of portal hypertension: a comparative study. Dig Surg. 2009; 26: 499-505.

17. Jiang XZ, Zhao SY, Luo H, Huang B, Wang CS, Chen L, et al. Laparoscopic and open splenectomy and azygoportal disconnection for portal hypertension. World J Gastroenterol. 2009; 15: 3421-3425.

18. Tsugawa K, Koyanagi N, Hashizume M, Tomikawa M, Ayukawa K, Akahoshi K, et al. A comparison of an open and laparoscopic appendectomy for patients with liver cirrhosis. Surg Laparosc Endosc Percutan Tech. 2001; 11: 189-194.

19. Cheung TT, Poon RT, Yuen WK, Chok KS, Jenkins CR, Chan SC, et al. Long-term survival analysis of pure laparoscopic versus open hepatectomy for hepatocellular carcinoma in patients with cirrhosis: a single-center experience. Ann Surg. 2013; 257: 506-511.

20. Belli G, Limongelli P, Fantini C, D’Agostino A, Cioffi L, Belli A, et al. Laparoscopic and open treatment of hepatocellular carcinoma in patients with cirrhosis. Br J Surg. 2009; 96: 1041-1048.

21. Belli G, D’Agostino A, Fantini C, Cioffi L, Belli A, Russolillo N, et als. Laparoscopic incisional and umbilical hernia repair in cirrhotic patients. Surg Laparosc Endosc Percutan Tech. 2006; 16: 330-333.

22. Carswell KA, Sagias FG, Murgatroyd B, Rela M, Heaton N, Patel AG. Laparoscopic versus open left lateral segmentectomy. BMC Surg. 2009; 9: 14.

23. Laurence JM, Tran PD, Richardson AJ, Pleass HC, Lam VW. Laparoscopic or open cholecystectomy in cirrhosis: a systematic review of outcomes and meta-analysis of randomized trials. HPB (Oxford). 2012; 14: 153-161.

Other Articles

Article Image 1

Case Series and a Review of Cannabinoid Hyperemesis Syndrome

Cannabinoid hyperemesis syndrome (CHS) is a condition observed in patients with chronic use of cannabis. It is characterized with GI symptoms including nausea, vomiting, abdominal pain and diarrhea. The patients tend to be chronic abusers for several years and experience these symptoms in a cyclical manner similar to the cyclical vomiting syndrome. They find relief after taking hot baths, a pathognomonic feature of CHS. We hereby describe 3 cases who presented with clinical features consistent with CHS. Cannabis acts through CB1 and CB2 receptors located in brain and gastrointestinal tract, respectively. There are no standard therapeutic measures available for management of CHS. We propose the idea of using short-acting cannabinoids including dronabinol. Also review of literature suggests treatments with drugs including clonidine, lorazepam and risperidone. Recent endeavors on legalization of recreational cannabis use have initiated several debates and we should be mindful of CHS as one of its long-term complications.

Yezaz A Ghouri¹, Jay Chouhan¹, Lauren Hoffman³ and Sushovan Guha¹,²*


Article Image 1

Pharmacological Characterization of Muscarinic Receptor Subtypes Involved in Carbachol-Induced Contraction of the Chicken Proventriculus

Present study was designed to characterize the postjunctional muscarinic acetylcholine receptor mediating contraction of the chicken proventriculus by using muscarinic receptor agonists and antagonists. Muscarinic agonists caused concentration-dependent contraction. The ranking order of pEC50 values were muscarine > arecaidine propargyl ester > oxotremorine M > carbachol > methacholine > arecoline > acetylcholine > bethanechol = McN-A343 = pilocarpine. The responses to carbachol were competitively antagonized by AF-DX116 (pKb =5.9), AF-DX384 (6.84), 4-DAMP (8.79), methoctramine (5.81), pirenzepine (6.78), p-F-HHSID (7.41), atropine (8.43),tropicamide (6.91), himbacine (7.01), AQ-RA741 (6.6) and dimethindene (6.73). The correlation of pKb of the chicken proventriculus with that of the mammalian M3 receptor was the highest among five muscarinic receptors. The proventriculus membrane contained a single class of [3 H]-quinuclidinyl benzilate binding sites. pKi values of the antagonists in a binding displacement study correlated with that of the M3 subtype. Pertussis toxin(100µg/kg, i.p. for 72h) significantly decreased the contraction induced by a low concentration of carbachol. In 4-DAMP mustard and AF-DX116-pretreated muscle strips, AF-DX116 shifted the concentration-response curve for oxotremorine M to the right in the presence of 5-hydroxytryptamine and forskolin. The pKb value (6.22) was significantly higher than that obtained in the normal condition (5.78). Isoproterenol increased cyclic AMP, and carbachol significantly decreased the isoproterenol-induced increase in cyclic AMP. The results indicated that a muscarinic agonist mainly acts on the M3 receptor to cause contraction of the chicken proventriculus but the possible involvement of M2 /M4 receptors cannot be excluded as demonstrated in mammalian gastrointestinal tract.

Takio Kitazawa¹*, Nahoko Kondo¹ and Tetsuro Taneike¹


Article Image 1

A Case Report on Ulcerative Colitis with Interventional Outcomes

Ulcerative Colitis (UC) is a mucosal disease that usually involves the rectum and extends proximally to involve all or part of the colon. Main causes are gut microbiota, dysregulation of the host’s immune system, genetic susceptibility and environmental factors. Active disease can be associated with a rise in acute phase reactants [C - reactive protein (CRP)], platelet count and Erythrocyte Sedimentation Rate (ESR) and a decrease in hemoglobin. Colonoscopy is used to assess disease activity and is often performed before treatment. In this case, recurrence UC was observed and it was treated with suitable therapy but some drug interactions like metronidizole additive effect with ofloxacin results in ST-T elevation and adverse effects like abdominal pain, burning pain in midsternal area radiating to epigastric region [Calcium+Vitamin-D] were seen. Those are monitored by the alternative therapy like dose management and drug alterations.

Sandeep RJ¹, Hari HC², Jyothsna RD² and Mahender V²*


Article Image 1

Prediction and Diagnosis of Fatty Liver in Dairy Cows

Fatty liver is defined as an accumulation of fat, mainly Triacylglycerol (TAG) in liver. Fatty liver in dairy cows is categorized into mild, moderate and severe fatty liver. Obesity in pregnant cow is crucial etiological factor for postpartal development of fatty liver. Namely, obese cows have a greater decrease in feed intake during the period around parturition and, therefore, have a more severe negative energy balance during early lactation which leads to increased lipolysis of adipose tissue. Non Esterified Fatty Acids (NEFA), released from the stored TAG in the adipose tissue, are readily taken up by liver. The excess of NEFA may be converted to TAG and deposit in liver. Liver biopsy is the only reliable method for the detection of fatty liver, especially for the determination of its severity through the estimation of total lipids and TAG. Ecography may be considered as noninvasive, on-farm method for diagnosis of fatty liver which is not commonly used do to the not widely achievable equipment. Since some metabolic and endocrine parameters are significantly correlated with fatty liver degree, they may be used as diagnostic indicators of fatty liver. The significance of those indicators for diagnosis of fatty liver is present in this review. Additionally, indicators that may be used for prediction of fatty liver are explained. Specially attention was given to glucose, NEFA, BHBA, liver enzymes, total bilirubin, total protein, albumin and urea as well as some hormones involved in lipid metabolism. Achievements of novel methods, like genomic and proteomic profiling of biological fluids of diseased cows, in providing tools for diagnosis and prognosis of this metabolic disease are presented.

Danijela Kirovski¹* and Zeljko Sladojevic²


Article Image 1

Primary Gastric Lymphoma

The treatment of primary gastric lymphoma is evolving in post-rituximab era. The role of Helicobacter pyroli eradication alone can cure not only Mucosa-Associated Lymphoepithelial Tumor (MALT) but also some of diffuse large B cell lymphoma with or without MALT component. The efficacy of rituximab containing chemotherapy is so effective that the role of surgery is overshadowed. There are many studies, although most of them were retrospective trials, however it highlights the current mainstay of immune-chemotherapy provided an outstanding long term survival more than 80-90%.H pylori In real world there are substantial patients may receive surgery first, yet still needs post-operative adjuvant chemotherapy for some of them has a risk of relapse of lymphoma. And recent studies showed there’s no statistical difference between the two modalities. The main reason for patients proceeded to surgery as primary treatment is the gastroenterologist preference and showed no difference in terms of progression free survival and overall survival. The rituximab was introduced to lymphoma treatment since 1999, and demonstrated a superior long term survival in diffuse large B cell lymphoma for R-CHOP relatively to CHOP regimen. The highly effective treatment made PGL being easily curable disease; furthermore there are new insights of why and how the antibiotic therapy as exclusive treatment for limited disease will be a mainstay in treating this malignancy. We make a proposal how to treat the primary gastric lymphoma and MALT, and highlight the changing treatment modalities with regards to the integration of Helicobacter pyroli eradication to conventional chemotherapy as well as the complimentary role of surgery and radiotherapy.

Ming-Chih Chang¹* and Sung-Hsin Kuo²*


Article Image 1

Bleeding Peptic Ulcer: Epidemiology, Treatment and Prognosis

Aims: The aim of this study was to demonstrate epidemiological, clinical and endoscopic characteristics of acute Upper Gi Bleeding (UGIB) with a focus on Peptic Ulcer Bleeding (PUB).

Methods: This study included 2198 consecutive patients that were referred to our emergency department due to acute Upper Gi Bleeding (UGIB) from January 2008 to December 2012. All patients under went urgent upper GI endoscopies within 24 hours of admission, and 842 patients diagnosed with PUB were enrolled and prospectively followed.

Results: The cumulative incidence of UIGB was 126/100000 for a 5-year period. Two out of five patients had a bleeding peptic ulcer, of which 440 (52.3%) patients had a bleeding gastric ulcer, 356 (42.3%) had a bleeding duodenal ulcer, 17 (2%) had both bleeding gastric and duodenal ulcers and 29 (3.5%) patients had bleeding ulcers on gastroenteric anastomosis. PUB was more common in men. Average patient age was 65.9 years. The majority of patients with PUB were taking agents that attenuate the cytoprotective function of the gastric and duodenal mucosa (57%).Half of the patients received a red blood cell transfusion, with a median of 2.2 units. Re-bleeding occurred in 77(9.7%) patients and 47 (5.9%) required surgical intervention. The thirty-day morality was 5.2%, and 10% of patients died from uncontrolled bleeding and concomitant diseases.

Conclusion: PUB is the main cause of UGIB, characterized by a significant re-bleeding rate and mortality.

Budimir I¹, Stojsavljevic S¹*, Nikolic M¹, Kralj D¹, Biscanin A¹, Kirigin LS², Zovak M³, Babic Z⁴, Bohnec S⁵ and Budimir I⁶


Article Image 1

An Update on Hepatorenal Syndrome

The Hepatorenal Syndrome (HRS) is one of many potential causes of Acute Kidney Injury (AKI) in patients with decompensated liver disease.

HRS is associated with poor prognosis and represents the end-stage of a sequence of reductions in renal perfusion induced by progressively severe hepatic injury.

The pathophysiology of HRS is complex with multiple mechanisms interacting simultaneously, although HRS is primarily characterised by renal vasoconstriction.

A recently revised diagnostic criteria and management algorithm for AKI has been developed for patients with cirrhosis, allowing physicians to commence treatment promptly.

Vasopressor therapy and other general management, such as antibiotic prophylaxis, need to be initiated while patients are assessed for eligibility for transplantation. Liver transplantation remains the treatment of choice for HRS but is limited by organ shortage.

Other management options, such as transjugular intrahepatic portosystemic shunt, renal replacement therapy and molecular absorbent recirculating system, may provide short term benefit for patients not responding medical therapy while awaiting transplantation.

Clinicians need to be aware of the pathophysiology and management principles of HRS to provide quality care for patients with multi-organ failure.

Samuel Chan*


Article Image 1

Abdominal CT Findings of Cholecystogastric Fistula

Enteric fistulas are abnormal connections between the gastrointestinal tract and other organs, chest or skin. Fistulas between the gall bladder and the gastrointestinal system are common [1]. Cholecystoduodenal and cholecystocolic fistulas are seen frequently while cholecystogstric ones are rare [2]. In our case, we accidentally discovered a cholecystogastric fistula in a 71 years old male patient with gastric adenocarcinoma in orally and intravenous contrast enhanced abdomen CT.

Husam Vehbi¹* and Cagri Agirgun²


Article Image 1

Post-Colonoscopy Colorectal Carcinomas (PostCRCs): Have we Improved Over Time?

Background and Aim: There is an increasing concern on Post-Colonoscopy Colorectal Carcinomas (PostCRCs). Little is known about how these figures have evolved over time. We aim to compare the rates of PostCRCs in two periods of time and identify the risk factors.

Methods: Retrospective control-case study in our Endoscopic Unit. We studied two separate intervals (March 2004-September 2011 and October 2011 - December 2016). In both periods of time all patients diagnosed with CRC were identified. Patients with a previous colonoscopy performed 12 to 60 months before were retrieved (cases) and compared with those who did not have a previous procedure (controls).

Results: 712 and 743 patients diagnosed with CRC in both periods of time. 24 patients in the first period (3.6%) and 28 patients in the second one (3.8%) had a previous colonoscopy performed. PostCRCs were mainly located on the right side of the colon (63% vs. 35% p=0.006 and 68% vs. 33% p< 0.001), were smaller in size (3.17 vs.4.46 p< 0.001 and 3.61 vs. 4.44 p=0.086), with a tendency to host a better TNM stage. No differences in sex and age were found.

More than half of PostCRCs (58.3% and 60.7%) were attributed to procedure causes, meanwhile10 PostCRCs in both periods were considered new developed CRCs.

Conclusions: Despite what could be expected, we did not find a decrease in the rate of PostCRCs over time. A combination of preventable as much as biological factors would account for their etiology.

María Lourdes Ruiz Rebollo¹* and María Fe Muñoz Moreno²


Article Image 1

Renal Metastasis from Mucinous Adenocarcinoma of the Colon in a 70 Year Old Male: A Case Report

Distal Metastasis of Colorectal Cancer (CRC) mostly spread to the lymph node, liver, peritoneum and lung. The kidney metastasis from colorectal cancer considered to be unusual and rare sites of metastasis. The most important factor which affects the prognosis of colorectal cancer is distal metastasis. The present study reported the case of a 70-yr-old Saudi man metastatic mucinous adenocarcinoma of the colon in the right kidney at the time of initial presentation.

Sultan H AlSaigh¹* and Aseel A AlSaeed²